Patricia S. Andrews

Board Director

Director

Glycomimetics Inc Oncolytics Biotech Inc

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€98k

▼ Sales (0 ops.)

—

Latest filing published 13 Feb 2026 for ONCOLYTICS BIOTECH INC, €26k. Read the official filing

Filing timeline

BuySale

Patricia S. Andrews

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Patricia S. Andrews: trading record in brief

Filings by Patricia S. Andrews span 2 companies, the busiest being Crescent Biopharma, Inc. and Oncolytics Biotech Inc. Over a trading history stretching from 18 May 2021 to 12 February 2026, the count stands at 5 filings.

No open-market sale appears; the market trades are 2 purchases worth €98k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. 2026 to date brings 1 purchase and no sales.

Most recently, on 13 February 2026, the filings show an open-market purchase worth €26k in Oncolytics Biotech Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.